Pin-Yi Wang

1.0k total citations
32 papers, 792 citations indexed

About

Pin-Yi Wang is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Pin-Yi Wang has authored 32 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 15 papers in Oncology and 13 papers in Immunology. Recurrent topics in Pin-Yi Wang's work include Virus-based gene therapy research (21 papers), CAR-T cell therapy research (14 papers) and Herpesvirus Infections and Treatments (6 papers). Pin-Yi Wang is often cited by papers focused on Virus-based gene therapy research (21 papers), CAR-T cell therapy research (14 papers) and Herpesvirus Infections and Treatments (6 papers). Pin-Yi Wang collaborates with scholars based in United States, Taiwan and Netherlands. Pin-Yi Wang's co-authors include Timothy P. Cripe, Chun‐Yu Chen, Brian Hutzen, Joe Conner, Craig T. Jordan, Luke Mugge, Simon P. Hogan, Andrey Kartashov, Artem Barski and Timothy Bushnell and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Pin-Yi Wang

30 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pin-Yi Wang United States 14 331 327 258 257 101 32 792
Alar Aints Sweden 13 233 0.7× 222 0.7× 454 1.8× 354 1.4× 112 1.1× 23 952
Thomas R. Bauer United States 19 161 0.5× 485 1.5× 539 2.1× 276 1.1× 57 0.6× 46 1.1k
Yoshiro Kamachi Japan 15 169 0.5× 128 0.4× 388 1.5× 309 1.2× 112 1.1× 24 1.1k
Tamás Schweighoffer Austria 15 207 0.6× 134 0.4× 314 1.2× 599 2.3× 44 0.4× 30 952
Nikolas T. Martin Canada 11 429 1.3× 397 1.2× 238 0.9× 431 1.7× 54 0.5× 13 909
S Nishikawa Japan 9 179 0.5× 214 0.7× 341 1.3× 476 1.9× 38 0.4× 13 970
Cecilia Frecha France 18 307 0.9× 569 1.7× 508 2.0× 204 0.8× 161 1.6× 35 993
Narda Whiting‐Theobald United States 14 321 1.0× 370 1.1× 332 1.3× 340 1.3× 42 0.4× 20 779
G. Reisbach Germany 16 511 1.5× 81 0.2× 258 1.0× 458 1.8× 173 1.7× 26 1.1k
Nancy Pech United States 15 217 0.7× 278 0.9× 299 1.2× 398 1.5× 47 0.5× 26 764

Countries citing papers authored by Pin-Yi Wang

Since Specialization
Citations

This map shows the geographic impact of Pin-Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pin-Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pin-Yi Wang more than expected).

Fields of papers citing papers by Pin-Yi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pin-Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pin-Yi Wang. The network helps show where Pin-Yi Wang may publish in the future.

Co-authorship network of co-authors of Pin-Yi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Pin-Yi Wang. A scholar is included among the top collaborators of Pin-Yi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pin-Yi Wang. Pin-Yi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Chia‐Hui, Ruei‐Nian Li, Pin-Yi Wang, et al.. (2025). Parvovirus B19 NS1 protein induces synovitis mimicking rheumatoid arthritis. Scientific Reports. 15(1). 28679–28679.
2.
Kipp, Jingjing L., Ryan D. Roberts, Nicolas Wein, et al.. (2024). Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma. SHILAP Revista de lepidopterología. 32(4). 200908–200908. 3 indexed citations
3.
Hutzen, Brian, Chun‐Yu Chen, Pin-Yi Wang, et al.. (2024). Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors. Frontiers in Immunology. 15. 1384623–1384623. 1 indexed citations
4.
Tseng, Chia‐Chun, Kuan‐Yu Chen, Pin-Yi Wang, et al.. (2023). The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies. International Journal of Molecular Sciences. 24(15). 11995–11995. 12 indexed citations
5.
Wang, Pin-Yi, Yu‐Hsuan Kuo, Ming‐Jen Sheu, et al.. (2023). Lymphocyte-Rich Hepatocellular Carcinoma with Multiple Lymphadenopathy and Positive Epstein–Barr Virus Encoding Region. SHILAP Revista de lepidopterología. 2023. 1–5. 2 indexed citations
6.
Cripe, Timothy P., Brian Hutzen, Mark A. Currier, et al.. (2022). Leveraging gene therapy to achieve long-term continuous or controllable expression of biotherapeutics. Science Advances. 8(28). eabm1890–eabm1890. 9 indexed citations
7.
Wedekind, Mary Frances, Katherine E. Miller, Chun‐Yu Chen, et al.. (2021). Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma. iScience. 24(7). 102759–102759. 4 indexed citations
8.
Ghonime, Mohammed G., Uksha Saini, Michael C. Kelly, et al.. (2021). Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy. Journal for ImmunoTherapy of Cancer. 9(10). e002939–e002939. 13 indexed citations
9.
Denton, Nicholas, Chun‐Yu Chen, Brian Hutzen, et al.. (2018). Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment. Molecular Therapy — Oncolytics. 11. 62–74. 44 indexed citations
10.
Hutzen, Brian, Chun‐Yu Chen, Pin-Yi Wang, et al.. (2018). Abstract A08: TGFβb inhibition improves oncolytic herpes viroimmunotherapy in murine models of rhabdomyosarcoma. Cancer Research. 78(19_Supplement). A08–A08. 1 indexed citations
11.
Hutzen, Brian, Chun‐Yu Chen, Pin-Yi Wang, et al.. (2017). TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma. Molecular Therapy — Oncolytics. 7. 17–26. 37 indexed citations
12.
Chen, Chun‐Yu, Pin-Yi Wang, Brian Hutzen, et al.. (2017). Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models. Scientific Reports. 7(1). 2396–2396. 70 indexed citations
13.
Wang, Pin-Yi, et al.. (2016). Abstract A14: Checkpoinblockade enhances oncolytic herpes virotherapy in immunosuppressive sarcoma models. Cancer Research. 76(5_Supplement). A14–A14. 1 indexed citations
14.
Cripe, Timothy P., Chun‐Yu Chen, Nicholas Denton, et al.. (2015). Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children. Molecular Therapy — Oncolytics. 2. 15015–15015. 20 indexed citations
15.
Friedman, Gregory K., Elizabeth A. Beierle, G. Yancey Gillespie, et al.. (2015). Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children. Molecular Therapy — Oncolytics. 2. 15016–15016. 12 indexed citations
16.
Bolyard, Chelsea, Ji Young Yoo, Pin-Yi Wang, et al.. (2014). Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer. Clinical Cancer Research. 20(24). 6479–6494. 26 indexed citations
17.
Leddon, Jennifer L., Chun‐Yu Chen, Mark A. Currier, et al.. (2014). Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity. Molecular Therapy — Oncolytics. 1. 14010–14010. 31 indexed citations
18.
Cripe, Timothy P., et al.. (2009). Targeting Cancer-initiating Cells With Oncolytic Viruses. Molecular Therapy. 17(10). 1677–1682. 62 indexed citations
19.
Young, Faith, Andrew Campbell, Johan Jansson, et al.. (2008). High-Risk Acute Lymphoblastic Leukemia Cells with bcr-abl and Ink4a/Arf Mutations Retain Susceptibility to Alloreactive T Cells. Biology of Blood and Marrow Transplantation. 14(6). 622–630. 5 indexed citations
20.
Wu, Mei‐Yi, Pin-Yi Wang, Shou‐Hwa Han, & Shie‐Liang Hsieh. (1999). The Cytoplasmic Domain of the Lymphotoxin-β Receptor Mediates Cell Death in HeLa Cells. Journal of Biological Chemistry. 274(17). 11868–11873. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alar Aints Breakdown of academic impact, for papers by Thomas R. Bauer Breakdown of academic impact, for papers by Yoshiro Kamachi Breakdown of academic impact, for papers by Tamás Schweighoffer Breakdown of academic impact, for papers by Nikolas T. Martin Breakdown of academic impact, for papers by S Nishikawa Breakdown of academic impact, for papers by Cecilia Frecha Breakdown of academic impact, for papers by Narda Whiting‐Theobald Breakdown of academic impact, for papers by G. Reisbach Breakdown of academic impact, for papers by Nancy Pech
Rankless by CCL
2026